Tevogen (TVGN) Total Non-Current Liabilities (2021 - 2026)

Tevogen Bio Holdings (TVGN) has 6 years of Total Non-Current Liabilities data on file, last reported at $14.8 million in Q1 2026.

• Quarterly Total Non-Current Liabilities rose 25.96% year-over-year to $14.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.8 million (up 25.96% YoY) and the FY2025 annual result came in at $12.6 million, up 25.3% from the prior year.
• Total Non-Current Liabilities climbed to $14.8 million in Q1 2026, from $12.6 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $99.9 million in Q4 2023 to a low of -$3.1 million in Q2 2024.
• A 5-year average of $16.8 million and a median of $14.8 million in 2026 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2023 — Total Non-Current Liabilities surged 563.8% — and 2024, when it plunged 118.84%.
• Tracing TVGN's Total Non-Current Liabilities over 5 years: stood at $15.1 million in 2022, then surged by 563.8% to $99.9 million in 2023, then slumped by 89.94% to $10.0 million in 2024, then grew by 25.3% to $12.6 million in 2025, then gained by 17.24% to $14.8 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $14.8 million (Q1 2026), $12.6 million (Q4 2025), and -$1.7 million (Q3 2025), per Business Quant data.